Mark53.com

Visit mark53.com
  • 3 months ago

    Last scanned

  • 12 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Mark53.com

Visit mark53.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

MARK53 | Krebstherapie: Bessere Effizienz – weniger Nebenwirkungen

Die Standard-Chemotherapie als Standard-Instrument für alle Krebspatienten, funktioniert nicht. Eine zielgerichtete Therapie für einige wenige…

Mark53.com thumbnail
Mark53.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Neue Medien Muennich GmbH, which reserves the following IP addresses for mark53.com: 85.13.141.8. Moreover, DNS used with this website include ns5.kasserver.com, ns6.kasserver.com.

  • 3 months ago

    Last scanned

  • 12 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

  • Hosting Company

    Neue Medien Muennich GmbH

  • IPs

    85.13.141.8

  • DNS

    ns5.kasserver.com

    ns6.kasserver.com

Whois

OWNERSHIP

  • Created

    2012-03-30

  • Expires

    2024-03-30

  • Owner

    REDACTED FOR PRIVACY

  • Registar

    REGISTRYGATE GMBH

  • Owner Emails

    info@domain-contact.org

Domain & Keywords

The registrar of mark53.com is REGISTRYGATE GMBH and the name expires on 2024-03-30. According to open source data, you can reach the owner at info@domain-contact.org but please make sure you have a good reason for unsolicited messages. Their country of residence is New Zealand.

  • chemotherapy
  • cancer therapy
  • biomarker
  • daniela kandioler
  • p53 gene test
  • predictive marker
  • efficient tumor therapy
  • tumor specific therapy
  • marker tests
  • clinical marker studies

Websites similar to mark53.com